FdaApplication
ANDA 219881
Identifiers
- fda_app_no: ANDA219881
Properties
| Property | Value |
|---|---|
| applicant_name | QILU PHARMACEUTICAL HAINAN CO LTD |
| application_type | ANDA |
| approval_date | 2026-02-03 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DOXORUBICIN HYDROCHLORIDE | DOXORUBICIN HYDROCHLORIDE | 50MG/25ML (2MG/ML) | INJECTABLE, LIPOSOMAL;INJECTION |
| DOXORUBICIN HYDROCHLORIDE | DOXORUBICIN HYDROCHLORIDE | 20MG/10ML (2MG/ML) | INJECTABLE, LIPOSOMAL;INJECTION |
2 products